Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study.
about
Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE StudyIdentification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP dataEducation attenuates the effect of medial temporal lobe atrophy on cognitive function in Alzheimer's disease: the MIRAGE studyMagnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patientsUsing Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomicsEvidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4Multiple etiologies for Alzheimer disease are revealed by segregation analysis.Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.Diagnosing Alzheimer's disease--non-clinicians and computerised algorithms together are as accurate as the best clinical practice.Magnetic resonance imaging traits in siblings discordant for Alzheimer disease.Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.Genetic association between endothelial nitric oxide synthase and Alzheimer disease.Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.
P2860
Q24792960-32D8BAF2-FFF8-47E8-908B-C8A51558F562Q33753746-041CA008-094B-433B-9343-F161081CB29AQ33846901-00293794-D203-47BC-B9A2-BC62188839C3Q35196310-78B20257-3413-4A9F-81BF-7FE3BB8CD07FQ35316963-BCFD4A22-900B-4AB5-8EEB-1521104BDCBAQ35882298-EE93CF1F-D672-4022-8E46-71B1F634E7CFQ35889556-6ACB8158-5EBB-413B-9DF4-96C2B2AFF5E5Q36790121-355927A2-855C-4930-9A89-CD4339B03BE0Q36832420-7C6B3A7F-5DE8-4AED-B4EF-8B9E5C81065AQ37423405-72FDC68B-9DB1-4A47-A3E2-A2239102A89AQ37653312-855C82C2-AA06-4910-A7EC-98EA620CC1AAQ50724901-A2DC7FC8-4F2B-4968-BD74-46EF2B548542Q50747108-A4C29519-7083-48F0-87D5-CE8B3A47A811Q50798207-A05A965E-22C9-432B-BEFC-6BD0B891390A
P2860
Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study.
@en
Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study.
@nl
type
label
Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study.
@en
Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study.
@nl
prefLabel
Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study.
@en
Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study.
@nl
P2093
P356
P1433
P1476
Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study.
@en
P2093
Auerbach S
Blackburn S
Connor-Lacke L
Growdon JH
Karlinsky H
P304
P356
10.1212/WNL.44.4.652
P407
P577
1994-04-01T00:00:00Z